Penthrox approved in Mexico
18 October 2017
ASX ANNOUNCEMENT
Penthrox approved in Mexico
Medical Developments International Limited (ASX: MVP) is delighted to announce it has received regulatory approval for the sale of Penthrox in Mexico. The Mexican Federal Commission for the Protection against Sanitary Risk (COFEPRIS) has approved Penthrox for use in patients with moderate to severe Trauma pain and for the relief of pain in patients who require analgesia for Surgical Procedures.
For the full ASX Announcement, please refer to the following link: ASX Announcement – Penthrox approved in Mexico